← FDA Drug Approvals (Drugs@FDA)

PEMETREXED

NDA · New Drug Application · Sponsor: ACTAVIS · Approved 2020-08-21

Drug application

FDA Application #

NDA208419

Application type

New Drug Application

Brand name

PEMETREXED

Generic name

PEMETREXED

Active ingredients

PEMETREXED

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

ACTAVIS

Manufacturer

Teva Pharmaceuticals, Inc.

First approval

2020-08-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown